Cargando…
Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials
Older adults continue to be underrepresented in cancer clinical trials, despite most cancer occurrence peaking in the later decades of life. Consequently, diagnostic and management strategies are commonly extrapolated from data on younger patients, thus challenging the delivery of informed cancer ca...
Autores principales: | Habr, Dany, McRoy, Lynn, Papadimitrakopoulou, Vassiliki A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562957/ https://www.ncbi.nlm.nih.gov/pubmed/33881547 http://dx.doi.org/10.1093/jnci/djab070 |
Ejemplares similares
-
Reimagining diversity in multiple myeloma clinical trials
por: Habr, Dany, et al.
Publicado: (2022) -
Hypertension in the older person: is age just a number?
por: Karayiannis, Christopher C.
Publicado: (2022) -
Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design
por: Dimou, Anastasios, et al.
Publicado: (2014) -
Patients at the Heart of the Scientific Dialogue: An Industry Perspective
por: Habr, Dany, et al.
Publicado: (2023) -
Age is just a number – and so is frailty: Strategies to inform resource allocation during the COVID-19 pandemic
por: Boreskie, Kevin F., et al.
Publicado: (2020)